By proceeding, you agree to our Terms of Use and Privacy Policy.
Vaccines Summit 2023 is an esteemed international conference organized by Scientia Meetings, bringing together participants from around the world. This highly anticipated event is scheduled to take place from November 13th to 15th, 2023, under the compelling theme of "next-generation vaccines treatment and diagnostics that save lives." The summit aims to provide an extensive platform for scientific discussions and collaboration, addressing key issues in the field of vaccine research.With a diverse range of sessions, Vaccines Summit-2023 offers a comprehensive symposium that covers various aspects of vaccine development and implementation. Attendees can expect insightful presentations, thought-provoking discussions, and cutting-edge research findings shared by renowned experts, both from academia and industry. This gathering of minds not only facilitates the exchange of knowledge but also presents an excellent opportunity to network with peers who share a passion for advancing vaccine science.One of the highlights of Vaccines Summit-2023 is its commitment to fostering fruitful business partnerships and advancements in the field. The conference provides unlimited opportunities for companies to explore business deals, enhance their products, and discover innovative solutions that can elevate their business prospects. Attendees will have the chance to engage in private one-to-one meetings with influential business representatives, including industry professionals, institutional investors, capitalists, and business development executives. These exclusive networking sessions can significantly increase the chances of successful marketing and collaboration in today's interconnected business world.Vaccines Summit-2023 promises to be a premier event for professionals and stakeholders in the vaccine industry. By attending this conference, participants will gain valuable insights into the latest developments in vaccine research, forge meaningful connections with peers, and explore potential avenues for business growth. The event's overarching goal is to contribute to the advancement of vaccine science, ultimately leading to the development of next-generation vaccines, treatments, and diagnostics that have the potential to save lives.
Examine the latest developments in next-generation vaccine treatment and diagnostics.
Explore the advancement of vaccine science, leading to the development of next-generation vaccines, treatments, and diagnostics that have the potential to save lives.
Indulge in insightful presentations, thought-provoking discussions, and cutting-edge research findings from renowned experts on advancing vaccine science.
Gain valuable insights into the latest developments in vaccine research, forge meaningful connections with peers, and explore potential avenues for business growth.
Scientia Meetings understand the importance of networking and collaboration. Conferences are not just about discussion, but to sharing knowledge and research work, new ideas, and a lot of opportunities.
Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL’s mission has been “Elevating ELISPOT to an Exact Science”.
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Our mission is to preserve biological material for future generations with secure, innovative storage and transport management. Our driving principles are preparation, accuracy, safety, and accountability.
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel t
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel techniques to conjugate, purify, and manufacture co
GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs ar
GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on vaccines against COVID-19; Hemorrhagi
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.